80 FR 36826 - Advisory Committee on Infant Mortality; Notice of Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 80, Issue 123 (June 26, 2015)
Health Resources and Services Administration
Federal Register Volume 80, Issue 123 (June 26, 2015)
| Page Range | 36826-36826 | |
| FR Document | 2015-15741 |
[Federal Register Volume 80, Number 123 (Friday, June 26, 2015)] [Notices] [Page 36826] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-15741] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Infant Mortality; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), notice is hereby given of the following meeting: Name: Advisory Committee on Infant Mortality (ACIM). Dates and Times: July 13, 2015, 8:30 a.m.-5:30 p.m. (EST), July 14, 2015, 8:30 a.m.-3:30 p.m. (EST). Place: Virtual via Webinar URL: https://hrsa.connectsolutions.com/sacim_seminar_200/. Call-In Number: 1.888.942.8170. Passcode: 3494113. Status: The meeting is open to the public with attendance limited to availability of call-in lines. For more details and registration, please visit the ACIM Web site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/InfantMortality/index.html). Purpose: The Committee provides advice and recommendations to the Secretary of Health and Human Services on the following: Department of Health and Human Services' programs that focus on reducing infant mortality and improving the health status of infants and pregnant women; and factors affecting the continuum of care with respect to maternal and child health care. The Committee focuses on outcomes following childbirth; strategies to coordinate myriad federal, state, local, and private programs and efforts that are designed to deal with the health and social problems impacting infant mortality; and the implementation of the Healthy Start program and Healthy People 2020 infant mortality objectives. Agenda: Topics that will be discussed include the following: HRSA Update; MCHB Update; Healthy Start Program Update; the PREEMIE Act; and, ACIM's recommendations for the HHS National Strategy to Address Infant Mortality, specifically, Strategy 5: Invest in adequate data, monitoring, and surveillance systems to measure access, quality, and outcomes. Proposed agenda items are subject to change as priorities dictate. The most current agenda will be posted on the ACIM Web site. Time will be provided for public comments limited to 5 minutes each. Comments are to be submitted in writing no later than 5:00 p.m. EST on Friday July 3, 2015. FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding the Committee should contact Michael C. Lu, M.D., M.P.H., Executive Secretary, ACIM, Health Resources and Services Administration, Room 18 W, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301) 443-2170. Individuals who are submitting public comments or who have questions regarding the meeting and location should contact David S. de la Cruz, Ph.D., M.P.H., ACIM Designated Federal Official, HRSA, Maternal and Child Health Bureau, telephone: (301) 443-0543, or email: David.delaCruz@hrsa.hhs.gov. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015-15741 Filed 6-25-15; 8:45 am] BILLING CODE 4165-15-P
![36826 Federal Register / Vol. 80, No. 123 / Friday, June 26, 2015 / Notices
nominated for consideration: (1) A Dates and Times: July 13, 2015, 8:30 Health Bureau, telephone: (301) 443–
statement that clearly states the name a.m.–5:30 p.m. (EST), July 14, 2015, 8:30 0543, or email: David.delaCruz@
and affiliation of the nominee, the basis a.m.–3:30 p.m. (EST). hrsa.hhs.gov.
for the nomination (i.e., specific Place: Virtual via Webinar URL:
Jackie Painter,
attributes such as expertise in bioethics, https://hrsa.connectsolutions.com/
evidence review, public health, sacim_seminar_200/. Call-In Number: Director, Division of the Executive Secretariat.
laboratory, maternal and child health, or 1.888.942.8170. Passcode: 3494113. [FR Doc. 2015–15741 Filed 6–25–15; 8:45 am]
clinical expertise in heritable disorders, Status: The meeting is open to the BILLING CODE 4165–15–P
which qualify the nominee for service in public with attendance limited to
this capacity), and that the nominee is availability of call-in lines. For more
willing to serve as a member of the details and registration, please visit the DEPARTMENT OF HEALTH AND
Committee; (2) the nominee’s name, ACIM Web site: http://www.hrsa.gov/ HUMAN SERVICES
address, and daytime telephone number advisorycommittees/mchbadvisory/
and the home/or work address, National Institutes of Health
InfantMortality/index.html).
telephone number, and email address; Purpose: The Committee provides Prospective Grant of Exclusive
and (3) a current copy of the nominee’s advice and recommendations to the License: The Development of an Anti-
curriculum vitae. Nomination packages Secretary of Health and Human Services TSLPR Chimeric Antigen Receptor
may be summited directly by the on the following: Department of Health (CAR) for the Treatment of Human
individual being nominated or by the and Human Services’ programs that Cancers
person/organization recommending the focus on reducing infant mortality and
candidate. improving the health status of infants AGENCY: National Institutes of Health,
The Department of Health and Human and pregnant women; and factors HHS.
Services will make every effort to ensure affecting the continuum of care with ACTION: Notice.
that the membership of the Committee respect to maternal and child health
is fairly balanced in terms of points of care. The Committee focuses on SUMMARY: This is notice, in accordance
view represented. Every effort is made outcomes following childbirth; with 35 U.S.C. 209 and 37 CFR part 404,
to ensure that individuals from a broad strategies to coordinate myriad federal, that the National Institutes of Health,
representation of geographic areas, state, local, and private programs and Department of Health and Human
gender, ethnic and minority groups, as efforts that are designed to deal with the Services, is contemplating the grant of
well as individuals with disabilities are health and social problems impacting an exclusive license to practice the
given consideration for membership. infant mortality; and the inventions embodied in U.S. Provisional
Appointments shall be made without implementation of the Healthy Start Patent Application 61/912,948 entitled
discrimination on the basis of age, program and Healthy People 2020 infant ‘‘Thymic Stromal Lymphopoietin
ethnicity, gender, sexual orientation, mortality objectives. Receptor-Specific Chimeric Antigen
and cultural, religious, or Agenda: Topics that will be discussed Receptors and Methods Using Same’’
socioeconomic status. include the following: HRSA Update; [HHS Ref. E–008–2014/0–US–01], U.S.
Individuals who are selected to be MCHB Update; Healthy Start Program Provisional Patent Application 61/
considered for appointment will be Update; the PREEMIE Act; and, ACIM’s 991,697 entitled ‘‘Thymic Stromal
required to provide detailed information recommendations for the HHS National Lymphopoietin Receptor-Specific
regarding their financial holdings, Strategy to Address Infant Mortality, Chimeric Antigen Receptors and
consultancies, and research grants or specifically, Strategy 5: Invest in Methods Using Same’’ [HHS Ref. E–
contracts. Disclosure of this information adequate data, monitoring, and 008–2014/1–US–01], PCT Patent
is necessary in order to determine if the surveillance systems to measure access, Application PCT/US2014/063096
selected candidate is involved in any quality, and outcomes. entitled ‘‘Thymic Stromal
activity that may pose a potential Proposed agenda items are subject to Lymphopoietin Receptor-Specific
conflict with the official duties to be change as priorities dictate. The most Chimeric Antigen Receptors and
performed as a member of the current agenda will be posted on the Methods Using Same’’ [HHS Ref. E–
Committee. ACIM Web site. 008–2014/2–PCT–01], and all related
Jackie Painter, Time will be provided for public continuing and foreign patents/patent
Director, Division of the Executive Secretariat. comments limited to 5 minutes each. applications for the technology family,
Comments are to be submitted in to Lentigen Technology, Inc. The patent
[FR Doc. 2015–15744 Filed 6–25–15; 8:45 am]
writing no later than 5:00 p.m. EST on rights in these inventions have been
BILLING CODE 4165–15–P
Friday July 3, 2015. assigned to and/or exclusively licensed
FOR FURTHER INFORMATION CONTACT: to the Government of the United States
DEPARTMENT OF HEALTH AND Anyone requiring information regarding of America.
HUMAN SERVICES the Committee should contact Michael The prospective exclusive licensed
C. Lu, M.D., M.P.H., Executive territory may be worldwide, and the
Health Resources and Services Secretary, ACIM, Health Resources and field of use may be limited to:
Administration Services Administration, Room 18 W, ‘‘The development of a TSLPR–CAR-
Parklawn Building, 5600 Fishers Lane, based immunotherapy using chimeric
Advisory Committee on Infant Rockville, Maryland 20857, telephone: antigen receptors (CARs) having:
Mortality; Notice of Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
(301) 443–2170. (1) The complementary determining
In accordance with section 10(a)(2) of Individuals who are submitting public region (CDR) sequences of either
the Federal Advisory Committee Act comments or who have questions (a) the anti-TSLPR antibody known as
(Pub. L. 92–463), notice is hereby given regarding the meeting and location 2D10 or
of the following meeting: should contact David S. de la Cruz, (b) the anti-TSLPR antibody known as
Name: Advisory Committee on Infant Ph.D., M.P.H., ACIM Designated Federal 3G11; and
Mortality (ACIM). Official, HRSA, Maternal and Child (2) a T cell signaling domain
VerDate Sep<11>2014 18:15 Jun 25, 2015 Jkt 235001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\26JNN1.SGM 26JNN1](https://thefederalregister.org/doc/80_FR_36949/page/1.svg)
Document Created: 2015-12-15 14:14:52
Document Modified: 2015-12-15 14:14:52
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Contact | Anyone requiring information regarding the Committee should contact Michael C. Lu, M.D., M.P.H., Executive Secretary, ACIM, Health Resources and Services Administration, Room 18 W, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301) 443-2170. | |
| FR Citation | 80 FR 36826 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR